-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 19, Zhejiang Medicine issued an announcement stating that it had recently received the "Drug Registration Certificate" with two specifications of 0.
Levofloxacin is a quinolone antibiotic and is suitable for respiratory infections, urinary system infections, reproductive system infections, skin and soft tissue infections, intestinal infections and other infections caused by sensitive bacteria.
Zhejiang Medicine submitted an application for drug registration (domestic production) to the State Drug Administration on January 7, 2020 and was accepted.